Evidence map›Paper›PMID 35911767›Full record

ArticleFrontiers in immunology2022

Altered Intestinal Microbiomes and Lipid Metabolism in Patients With Prolonged Disorders of Consciousness.

Jie Yu, Qisheng Cheng, Fangping He, Fanxia Meng, Yamei Yu, Chuan Xu, Xinrui Wen, Lirong Hong, Jian Gao, Jingqi Li and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Observational
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Jie YuDepartment of Neurology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Qisheng ChengDepartment of Neurology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Fangping HeDepartment of Neurology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Fanxia MengDepartment of Neurology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Yamei YuDepartment of Neurology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Zhejiang, China.
Chuan XuDepartment of Neurology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Xinrui WenDepartment of Neurology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Lirong HongDepartment of Rehabilitation, Hangzhou Hospital of Zhejiang Armed Police Corps, Hangzhou, China.
Jian GaoDepartment of Rehabilitation, Hangzhou Mingzhou Brain Rehabilitation Hospital, Hangzhou, China.
Jingqi LiDepartment of Rehabilitation, Hangzhou Mingzhou Brain Rehabilitation Hospital, Hangzhou, China.
Gang PanState Key Lab of Computer Aided Design & Computer Graphics, Hangzhou, China.
Ming D LiState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University School of Medicine, Hangzhou, China.
Benyan LuoDepartment of Neurology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Zhejiang University · CNSir Run Run Shaw Hospital · CNZhejiang Police College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intestinal microbiota regulate the brain function of the host through the production of a myriad of metabolites and are associated with various neurological diseases. Understanding the intestinal microbiome of patients with prolonged disorders of consciousness (DoC) is important for the evaluation and treatment of the disease. To investigate the differences in the intestinal microbiome and short-chain fatty acids (SCFAs) among patients in a vegetative state (VS), a minimally conscious state (MCS), and emerged from MCS (EMCS), as well as the influence of antibiotics on these patients, 16S ribosomal RNA (16S rRNA) sequencing and targeted lipidomics were performed on fecal samples from patients; in addition, analysis of the electroencephalogram (EEG) signals was performed to evaluate the brain function of these patients. The results showed that the intestinal microbiome of the three groups differed greatly, and some microbial communities showed a reduced production of SCFAs in VS patients compared to the other two groups. Moreover, reduced microbial communities and five major SCFAs, along with attenuated brain functional connectivity, were observed in MCS patients who were treated with antibiotics compared to those who did not receive antibiotic treatment, but not in the other pairwise comparisons. Finally, three genus-level microbiota-

Indexed as

Gastrointestinal MicrobiomeAnti-Bacterial AgentsConsciousnessFatty Acids, VolatileHumansLipid MetabolismPersistent Vegetative StateRNA, Ribosomal, 16SAnti-Bacterial AgentsFatty Acids, VolatileRNA, Ribosomal, 16Sbiomarkersbrain functional connectivityintestinal microbiomeprolonged disorders of consciousnessshort-chain fatty acid

Identifiers

PMID35911767
PMCPMC9326017
OpenAlexW4285087662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.